Starbucks and 3 Stocks With New Analyst Ratings and Price Targets
Iconix Brand Group, Inc. (NASDAQ:ICON): Current Price: $22.74
Brean Murray has increased Iconix estimates due to the acquisition of the Buffalo brand. The firm gives the stock a Buy rating.
Merck & Co. Inc. (NYSE:MRK): Current Price: $41.33
According to Credit Suisse, Merck’s risk/reward is attractive ahead of potential interim Vytorin IMPROVE-IT study data in mid–March. The firm gives the shares an Outperform rating.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Asia Entertainment & Resources (NASDAQ:AERL): Current Price: $4.44
Sterne Agee views Asia Entertainment weakness a buying opportunity.
Starbucks Corp. (NASDAQ:SBUX): Current Price: $56.05
Starbucks reported in-line Q1 EPS, which influences Argus to predict that the company’s new products will boost comps during FY13. The firm keeps its Buy rating and a $64 price target on the stock.
Don’t Miss: Why Did Facebook’s 10-K Scare Investors?